← Ticker index
MRNA
Ticker
MRNA
Moderna Inc.
Healthcare
Congressional Trades
34
by 4 members
Ticker disclosure brief
Congressional disclosure records for MRNA
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Ro Khanna
BUY · 2026-06-30
Largest range
$1K – $15K
Ro Khanna
Longest observed gap
39d
Ro Khanna
Highest 30d vs SPY
154.9%
Ro Khanna
Purchase rows
17
50%
Sale rows
17
50%
Disclosed midpoint
$272K
range estimate
Unique Traders
4
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats31 · 91%
Republicans3 · 9%
Federal awards
all →- 2026-06-08$30KDepartment of Health and Human ServicesVACCINES FOR ADULTS EO 14398
- 2026-05-28$8.1MDepartment of Health and Human ServicesFY26-27 PEDIATRIC COVID VACCINES EO 14398
- 2026-05-28$573KDepartment of Health and Human ServicesFY26-27 ADULT COVID VACCINES EO 14398
Lobbying filings
all →- 2026-07-14$100KMODERNA US INC.Issues related to vaccines, drug discovery, development and related issues.
- 2026-07-10$20KMODERNA INC.Tax Reform - Restoring the Orphan Drug Tax Credit.
- 2026-07-08$30KMODERNATX INC.Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 41, 45C, 951A, and 250. (H.R. 1414).
- 2026-04-20$50KMODERNATX INC.Issues related to COVID 19 vaccines, mRNA drug discovery, drug development and related issues.
- 2026-04-20$50KMODERNA INC.Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's delay in reviewing Moderna's flu vaccine
- 2026-04-20$20KSTANTON PARK GROUP LLC ON BEHALF OF MODERNATX INC.Issues related to COVID 19 vaccines, mRNA drug discovery, drug development and related issues.
- 2026-04-18$80KMODERNA US INC.Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain
- 2026-04-17$190KMODERNA INC.Vaccine Policy, FDA Vaccine Approvals
- 2026-04-15$80KMODERNA US INC.Issues related to vaccines, drug discovery, development and related issues.
- 2026-04-10$20KMODERNA INC.Tax Reform - Restoring the Orphan Drug Tax Credit.
Loading trade analytics…
All Disclosed Trades
Page 2 · 9 of 34 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2024-10-14 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2024-08-02 | DRo Khanna | SELL | $1K – $15K | 35d | receipt → |
| 2024-08-02 | DRo Khanna | SELL | $1K – $15K | 35d | receipt → |
| 2024-04-23 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2024-04-23 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2024-03-20 | DRo Khanna | SELL | $1K – $15K | 16d | receipt → |
| 2024-03-20 | DRo Khanna | SELL | $1K – $15K | 16d | receipt → |
| 2024-02-01 | DJosh Gottheimer | SELL | $1K – $15K | 35d | receipt → |
| 2024-02-01 | DJosh Gottheimer | SELL | $1K – $15K | 35d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.